Comparison of the cobas human papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests

Journal of Clinical Microbiology

Volumn 50, Issue 1, 2012, Pages 61-65

  Gage, Julia C ^a   Sadorra, Mark ^b   LaMere, Brandon J ^c   Kail, Randi ^b   Aldrich, Carrie ^d   Kinney, Walter ^c   Fetterman, Barbara ^c   Lorey, Thomas ^c   Schiffman, Mark ^a   Castle, Philip E ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c KAISER PERMANENTE   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e American Society for Clinical Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CARCINOGENICITY; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC TEST APPROVAL; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREDICTION; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UNITED STATES; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

EID: 84555196127     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05989-11     Document Type: Article

References (16)

1. Castle PE, et al. 2009. Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J. Clin. Microbiol. 47:3344-3347.
2. Castle PE, et al. 2008. Human papillomavirus genotype specificity of hybrid capture 2. J. Clin. Microbiol. 46:2595-2604.
3. Castle PE, et al. 2011. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of theATHENA study. Lancet Oncol. 12:880-890.
4. Froberg M, Johansson B, Hjerpe A, Andersson S. 2008. Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities. Br. J. Cancer. 99:563-568.
5. Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. 2008. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol. Biomarkers Prev. 17:1248-1254.
6. Katki HA, et al. 2011. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 12:663-672.
7. Khan MJ, et al. 2005. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J. Natl. Cancer Inst. 97:1072-1079. (Pubitemid 41417924)
8. Kovacic MB, et al. 2006. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res. 66:10112-10119. (Pubitemid 44672065)
9. LaMere BJ, et al. 2007. Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort. J. Virol. Methods 146:80-85. (Pubitemid 350030939)
10. Roche Molecular Diagnostics. 2008. AMPLICOR human papillomavirus test (package insert). Roche Molecular Diagnostics, Pleasanton, CA.
11. Sargent A, et al. 2008. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br. J. Cancer 98:1704-1709. (Pubitemid 351684674)
12. Schiffman M, et al. 2005. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337:76-84. (Pubitemid 40725441)
13. Stoler MH, et al. 2011. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am. J. Clin. Pathol. 135:468-475.
14. Szarewski A, et al. 2008. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol. Biomarkers Prev. 17:3033-3042.
15. Wright, TC, Jr, et al. 2003. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am. J. Obstet. Gynecol. 189:295-304.
16. Wright TC, Jr, et al. 2007. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J. Low. Genit. Tract Dis. 11:223-239.